Recent Finacing
Recent Raise
Antag Therapeutics is a clinical-stage biopharmaceutical company developing GIPR antagonist peptide therapies for obesity and cardiometabolic disease, including once-weekly subcutaneous AT-7687 for combination or maintenance use; FDA IND accepted.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
